Results 31 to 40 of about 2,813 (193)
The utility of radiotherapy as a means of palliating symptoms due to metastatic cancer is well-accepted. A growing body of literature suggests that radiotherapy may play a role beyond palliation in some patients with low-burden metastatic disease. Recent
William Tyler Turchan +2 more
doaj +1 more source
Metastasis-directed therapy for oligometastasis and beyond
AbstractMetastasis-directed therapy (MDT)—local therapy that is intended to eradicate specific metastatic lesions—has hitherto been used with varying degrees of clinical efficacy and acceptance as a meaningful therapy for metastatic disease. Over the past 25 years, however, the momentum for using MDT to manage patients with metastatic solid tumours has
Beckham, Thomas H. +3 more
openaire +3 more sources
Background Abdominal/pelvic lymph node (LN) oligometastasis, a pattern of treatment failure, is observed occasionally, and radiotherapy may work as salvage therapy. The optimal prescription dose, however, is yet to be determined.
Makoto Ito +10 more
doaj +1 more source
Surgical Management of Metastatic Breast Cancer: A Mini Review
Breast cancer with distant metastases is a systemic disease. While systemic therapies are the main treatment strategy, locoregional therapy for metastatic breast cancer (MBC) is generally palliative only.
Takayuki Ueno
doaj +1 more source
Revisiting a Null Hypothesis: Exploring the Parameters of Oligometastasis Treatment [PDF]
In the treatment of patients with metastatic cancer, the current paradigm states that metastasis-directed therapy does not prolong life. This paradigm forms the basis of clinical trial null hypotheses, where trials are built to test the null hypothesis that patients garner no overall survival benefit from targeting metastatic lesions.
Scarborough, Jessica A. +3 more
openaire +2 more sources
Oligometastasis and local ablation in the era of systemic targeted and immunotherapy [PDF]
Abstract Background During these last years, new agents have dramatically improved the survival of the metastatic patients. Oligometastases represent a continuous field of interest in which the integration of metastases-directed therapy and drugs could further improve the oncologic outcomes.
Mazzola, Rosario +11 more
openaire +5 more sources
Accelerating the development of therapeutic strategy for oligometastasis [PDF]
Metastasis is the principal cause of death among a large majority of cancer patients because of their systemic nature and the resistance of disseminated tumor cells to existing therapeutic agents. Patients who developed distant metastasis from lung cancers had been best served with palliative-intent systemic therapies.
openaire +2 more sources
The role of immunotherapy in combination with oligometastasis-directed therapy: a narrative review [PDF]
Metastatic disease is a significant cause of morbidity and mortality among patients with cancer. Patients with oligometastatic cancer represent a subset of the metastatic population with a limited amount of disease that has metastasized distantly and progresses at a slow pace and thus has the potential to be cured with metastasis-directed local therapy.
William Tyler, Turchan, Steven J, Chmura
openaire +2 more sources
Oligometastasis and oligo-recurrence: more than a mirage [PDF]
The standard treatment choice for cancer metastasis has been systemic management, including cytotoxic chemotherapy, hormonal manipulation, and targeted therapy. Emerging evidence has shown an oligometastatic state, an intermediate state between limited primary cancer and polymetastatic cancer, in which local therapy for metastatic lesions results in ...
Huang, Fang, Wu, Gang, Yang, Kunyu
openaire +2 more sources
A 48-year-old woman with regional recurrences of breast cancer in the axillar and supraclavicular regions was referred to our hospital. Under the diagnosis of recurrent luminal breast cancer with a high Ki-67 labeling index of >30% and a disease ...
Suzuka Fujii +2 more
doaj +1 more source

